search button

Antitumor effect of 22-oxacalcitriol on estrogen receptor-negative MDA-MB-231 tumors in athymic mice.

  • Authors:
    • H Matsumoto
    • Y Iino
    • Y Koibuchi
    • T Andoh
    • Y Horii
    • H Takei
    • J Horiguchi
    • M Maemura
    • T Yokoe
    • Y Morishita

  • View Affiliations

  • Published online on: March 1, 1999     https://doi.org/10.3892/or.6.2.349
  • Pages: 349-401
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The purpose of this study was to evaluate the usefulness of 22-oxacalcitriol (OCT) in the treatment of estrogen receptor (ER)-negative breast cancer. The antitumor effect of this agent and its effect combined with doxifluridine (5'-DFUR) on MDA-MB-231 tumors in female athymic mice were investigated. We also examined the effect of OCT on the expression of vascular endothelial growth factor (VEGF) which had been reported to generate angiogenesis in tumors. OCT significantly suppressed the growth of tumors without inducing hypercalcemia in a dose dependent manner. The effect of OCT combined with 5'-DFUR did not exceed the effect of a single agent therapy. The expressions of VEGF analyzed by enzyme-linked immunosorbent assay were significantly decreased in the OCT-treated group. These results suggest that OCT may partially suppress tumor growth by inhibiting neovascularization and it would likely have positive application as a treatment of ER-negative breast cancer.

Related Articles

Journal Cover

Mar-Apr 1999
Volume 6 Issue 2

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

  • Journal Metrics
  • Impact Factor: 4.2
  • Ranked Oncology
    (total number of cites)
  • CiteScore: 8.4
  • CiteScore Rank: Q1: #68/366 Oncology
  • Source Normalized Impact per Paper (SNIP): 0.786
  • SCImago Journal Rank (SJR): 0.812
International Symposium on Molecular Medicine Conference Banner
The Cancer Story
World Congress on Advances in Oncology and International Symposium on Molecular Medicine Conference Banner
World Academy Of Sciences Banner
Heyday Road Banner

0

Copy and paste a formatted citation
x
Spandidos Publications style
Matsumoto H, Iino Y, Koibuchi Y, Andoh T, Horii Y, Takei H, Horiguchi J, Maemura M, Yokoe T, Morishita Y, Morishita Y, et al: Antitumor effect of 22-oxacalcitriol on estrogen receptor-negative MDA-MB-231 tumors in athymic mice.. Oncol Rep 6: 349-401, 1999
APA
Matsumoto, H., Iino, Y., Koibuchi, Y., Andoh, T., Horii, Y., Takei, H. ... Morishita, Y. (1999). Antitumor effect of 22-oxacalcitriol on estrogen receptor-negative MDA-MB-231 tumors in athymic mice.. Oncology Reports, 6, 349-401. https://doi.org/10.3892/or.6.2.349
MLA
Matsumoto, H., Iino, Y., Koibuchi, Y., Andoh, T., Horii, Y., Takei, H., Horiguchi, J., Maemura, M., Yokoe, T., Morishita, Y."Antitumor effect of 22-oxacalcitriol on estrogen receptor-negative MDA-MB-231 tumors in athymic mice.". Oncology Reports 6.2 (1999): 349-401.
Chicago
Matsumoto, H., Iino, Y., Koibuchi, Y., Andoh, T., Horii, Y., Takei, H., Horiguchi, J., Maemura, M., Yokoe, T., Morishita, Y."Antitumor effect of 22-oxacalcitriol on estrogen receptor-negative MDA-MB-231 tumors in athymic mice.". Oncology Reports 6, no. 2 (1999): 349-401. https://doi.org/10.3892/or.6.2.349